May 4, 2020
Talis Biomedical Corporation announces the appointment of Kim Popovits to the company’s Board of Directors
Talis Biomedical Corporation announces the appointment of Kim Popovits, former Chairman of the Board, President…
August 29, 2018
Talis Biomedical Corporation awarded $5.6M by NIH
To fund development of clinically impactful Point-of-Care diagnostics for Antimicrobial-Resistant Bacteria https://www.prnewswire.com/news-releases/talis-biomedical-corporation-awarded-5-6m-by-nih-300664593.html
August 29, 2018
Talis Bio awarded $4.4M by CARB-X
To fund development of rapid point-of-care diagnostic tests for pathogen identification and antibiotic susceptibility https://www.prnewswire.com/news-releases/talis-biomedical-corporation-awarded-4-4m-by-carb-x-300646438.html…
March 16, 2018
Rapid pathogen-specific phenotypic antibiotic susceptibility testing using digital LAMP quantification in clinical samples
Reducing the time required to determine whether a bacterial sample is resistant to an antibiotic…
January 8, 2018
No progress seen in reducing antibiotics among outpatients
Overuse contributes to drug-resistant infections, excess costs Despite public health campaigns aimed at reducing unnecessary…
November 18, 2016
Commentary calls for global stewardship collaboration
A commentary today in The Lancet Infectious Diseases urges more international collaboration in the fight…
